325 related articles for article (PubMed ID: 23585573)
1. Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.
Lyon D; Elmore L; Aboalela N; Merrill-Schools J; McCain N; Starkweather A; Elswick RK; Jackson-Cook C
Biol Res Nurs; 2014 Apr; 16(2):160-74. PubMed ID: 23585573
[TBL] [Abstract][Full Text] [Related]
2. Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.
Alhareeri AA; Archer KJ; Fu H; Lyon DE; Elswick RK; Kelly DL; Starkweather AR; Elmore LW; Bokhari YA; Jackson-Cook CK
Breast Cancer Res; 2020 Dec; 22(1):137. PubMed ID: 33276807
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Psychoneurological Symptoms and Symptom Clusters in Women with Breast Cancer Undergoing Treatment: Influence on Quality of Life.
Durán-Gómez N; López-Jurado CF; Nadal-Delgado M; Montanero-Fernández J; Palomo-López P; Cáceres MC
Semin Oncol Nurs; 2023 Aug; 39(4):151451. PubMed ID: 37217435
[TBL] [Abstract][Full Text] [Related]
4. Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.
Aboalela N; Lyon D; Elswick RK; Kelly DL; Brumelle J; Bear HD; Jackson-Cook C
PLoS One; 2015; 10(7):e0133380. PubMed ID: 26177092
[TBL] [Abstract][Full Text] [Related]
5. Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year.
Yang GS; Mi X; Jackson-Cook CK; Starkweather AR; Lynch Kelly D; Archer KJ; Zou F; Lyon DE
Epigenetics; 2020 May; 15(5):499-510. PubMed ID: 31793401
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.
Smith AK; Conneely KN; Pace TW; Mister D; Felger JC; Kilaru V; Akel MJ; Vertino PM; Miller AH; Torres MA
Brain Behav Immun; 2014 May; 38():227-36. PubMed ID: 24583204
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer.
Lyon DE; Starkweather A; Yao Y; Garrett T; Kelly DL; Menzies V; Dereziński P; Datta S; Kumar S; Jackson-Cook C
Biol Res Nurs; 2018 Mar; 20(2):227-236. PubMed ID: 29258398
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Markers, Metabolic Profile, and Psychoneurological Symptoms in Women with Breast Cancer: A Literature Review.
Al-Bashaireh AM; Khraisat O; Alnazly EK; Aldiqs M
Cureus; 2021 Nov; 13(11):e19953. PubMed ID: 34976536
[TBL] [Abstract][Full Text] [Related]
9. Epigenomics and breast cancer.
Lo PK; Sukumar S
Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Pathways Associated With Psychoneurological Symptoms in Children With Cancer Receiving Chemotherapy.
Bai J; Withycombe J; Eldridge RC
Biol Res Nurs; 2022 Jul; 24(3):281-293. PubMed ID: 35285272
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic reprogramming in breast cancer: from new targets to new therapies.
Katz TA; Huang Y; Davidson NE; Jankowitz RC
Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.
Dworkin AM; Huang TH; Toland AE
Semin Cancer Biol; 2009 Jun; 19(3):165-71. PubMed ID: 19429480
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics as a therapeutic target in breast cancer.
Connolly R; Stearns V
J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
15. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer.
Starkweather A; Kelly DL; Thacker L; Wright ML; Jackson-Cook CK; Lyon DE
Support Care Cancer; 2017 Jan; 25(1):167-176. PubMed ID: 27599815
[TBL] [Abstract][Full Text] [Related]
16. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study.
Yao S; Hu Q; Kerns S; Yan L; Onitilo AA; Misleh J; Young K; Lei L; Bautista J; Mohamed M; Mohile SG; Ambrosone CB; Liu S; Janelsins MC
Clin Epigenetics; 2019 Mar; 11(1):45. PubMed ID: 30867049
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
[TBL] [Abstract][Full Text] [Related]
18. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
20. Cancer epigenetics: a perspective on the role of DNA methylation in acquired endocrine resistance.
Trimarchi MP; Mouangsavanh M; Huang TH
Chin J Cancer; 2011 Nov; 30(11):749-56. PubMed ID: 22035855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
